Recital 2, Regulation (EU) 2024/2899

In force

The Commission received an application in accordance with Article 10 of Regulation (EC) No 767/2009 to update the list of intended uses by adding to the use for the particular nutritional purpose ‘Reduction of the risk of milk fever and subclinical hypocalcaemia’ glycosylated 1,25-dihydroxycholecalciferol from Solanum glaucophyllum extract. This request has been examined taking into account the opinion of the European Food Safety Authority (‘the Authority’) on this feed additive adopted on 29 June 2022 [EFSA Journal 2022;20(8):7434.] which showed that glycosylated 1,25-dihydroxycholecalciferol from Solanum glaucophyllum extract, administered orally in a complementary feed in the form of a bolus in a period from 9 days before calving to immediately before calving, has the potential to prevent hypocalcaemia in dairy cows when applied as in the animal studies evaluated. In those studies, the bolus was complemented by a feed containing appropriate levels of calcium and magnesium.